While at the California Dialysis Conference last week, I attended a thought-provoking session with a panel discussion between three medical directors from the largest dialysis organizations in the U.S. – Davita, Fresenius and U.S. Renal: Dr. Allen Nissenson, Dr. Dinesh Chatoth and Dr. Stan Lindenfeld, respectively. These physicians grappled with many issues affecting dialysis patients nationwide.
As the topic turned towards the Centers for Medicare & Medicaid Services' (CMS) goal to have alternative payment models implemented in 80 percent of the Medicare population by the year 2020, the trio discussed the benefits of the new renal Accountable Care Organization (ESCO), including the unquestionable benefit of providing integrated care for patients with kidney disease. While these doctors agree that cost savings are an ultimate driver, by providing comprehensive services including palliative care, our medical community will be able to provide an alternative to dialysis and have painfully honest conversations about the benefits and challenges of treatment, particularly for the frail elderly. Surprisingly, at least to me, frailty has a medical definition. Frailty is identified when a patient meets three out of five criteria: weight loss (10 or more pounds within the past year), muscle loss, a feeling of fatigue, slow walking speed and low levels of physical activity. With aging frailty comes naturally; patients over 75 represent our largest growing segment with chronic kidney disease – the precursor to kidney failure.